Else Nutrition Holdings Inc (OTCQX:BABYF, TSX-V:BABY). said it has signed an online distribution agreement with Walmart.com and will be expanding into Walmart’s eCommerce marketplace by Q4, 2021 with its Plant-Based Complete Nutrition products for Toddlers.
“Entering Walmart.com is a highly significant milestone for the Company,” said Hamutal Yitzhak, CEO and co-Founder of Else Nutrition in a statement. “The sheer size of Walmart.com will allow us to reach thousands of new families and enable us to scale significantly over the next 3 years,” she added.
READ: Else Nutrition set to launch online plant-based toddler product sales on Kroger grocery platforms by 4Q
According to eMarketer, Walmart’s US eCommerce sales prior to the pandemic were $30 billion and are projected to hit over $64 billion by the end of 2021.
Walmart.com’s traffic was much higher the past year than pre-pandemic levels. Online shopping, particularly in the grocery and FMCG segment (Fast Moving Consumer Goods), has undergone a surge in popularity due to the pandemic.
Walmart was the largest United States grocery retailer in 2019 with 65% of its US$510.329 billion sales coming from US operations.
Else Nutrition is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula.
The company - formerly INDI - won the "2017 Best Health and Diet Solutions" award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon.
Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children's Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children's Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
Contact the author at jon.hopkins@proactiveinvestors.com